maaf email atau password anda salah

Payoffs for doctors

Monday, November 11, 2019

The long-standing dubious practice of giving payoffs to doctors by pharmaceutical companies continues even though the minister of health has issued a circular banning it three years ago.

arsip tempo : 173056540222.

Packaging process of one of drugs produced by the Kalbe group in Jakarta, September 2018./ TEMPO/Amston Probel. tempo : 173056540222.

 

Fierce competition between companies in the drug market, marketers rushing to meet sales targets, and demands on doctors to meet certain conditions to be able to practice medicine have made it difficult to eliminate such payouts.

The spotlight is on Kalbe Farma. With 1,300 people marketing their products, Kalbe had the highest sales numbers compared to other pharmaceutical companies. From the pharmaceutical division alone the company has

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

  • Tempo English Monday, November 11, 2019

  • Tempo English Monday, November 11, 2019

  • Tempo English Monday, November 11, 2019

  • Tempo English Monday, November 11, 2019

More exclusive contents

  • October 28, 2024

  • October 21, 2024

  • October 14, 2024

  • October 7, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe